Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity.
Saved in:
| Title: | Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity. |
|---|---|
| Authors: | Herrmann A; Immunic AG, Gräfelfing, Germany. Electronic address: alexandra.herrmann@imux.com., Gege C; Immunic AG, Gräfelfing, Germany. Electronic address: christian.gege@imux.com., Wangen C; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: christina.wangen@uk-erlangen.de., Wagner S; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: sabrina.wagner@uk-erlangen.de., Kögler M; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: melanie.koegler@uk-erlangen.de., Cordsmeier A; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: arne.cordsmeier@uk-erlangen.de., Irrgang P; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: pascal.irrgang@uk-erlangen.de., Ip WH; Leibniz Institute of Virology, Hamburg, Germany. Electronic address: winghang.ip@leibniz-liv.de., Weil T; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: tatjanaweil@yahoo.de., Hunszinger V; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: victoria.hunszinger@uni-ulm.de., Groß R; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: ruediger.gross@uni-ulm.de., Heinen N; Ruhr-University Bochum, Department of Molecular and Medical Virology, Bochum, Germany. Electronic address: natalie.heinen@ruhr-uni-bochum.de., Pfaender S; Leibniz Institute of Virology, Hamburg, Germany; Ruhr-University Bochum, Department of Molecular and Medical Virology, Bochum, Germany; University of Luebeck, Department of Natural Sciences, Institute of Virology and Cell Biology, Lübeck, Germany. Electronic address: stephanie.pfaender@leibniz-liv.de., Reuter S; University Hospital Essen - Ruhrlandklinik, Department of Pulmonary Medicine, Experimental Pneumology, Essen, Germany. Electronic address: sebastian.reuter@rlk.uk-essen.de., Klopfleisch R; Institute for Animal Pathology, Freie Universität Berlin, Berlin, Germany. Electronic address: robert.klopfleisch@fu-berlin.de., Uhlig N; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: nadja.uhlig@izi.fraunhofer.de., Eberlein V; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: valentina.eberlein@izi.fraunhofer.de., Issmail L; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: leila.issmail@izi.fraunhofer.de., Grunwald T; Fraunhofer Institute for Cell Therapy and Immunology, Preclinical Validation, Leipzig, Germany. Electronic address: thomas.grunwald@izi.fraunhofer.de., Hietel B; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Halle, Germany. Electronic address: benjamin.hietel@izi.fraunhofer.de., Cynis H; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Halle, Germany; Junior Research Group 'Immunomodulation in Pathophysiological Processes', Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany. Electronic address: holger.cynis@izi.fraunhofer.de., Münch J; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: jan.muench@uni-ulm.de., Sparrer KMJ; Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Electronic address: konstantin.sparrer@uni-ulm.de., Ensser A; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: armin.ensser@fau.de., Tenbusch M; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: matthias.tenbusch@fau.de., Dobner T; Leibniz Institute of Virology, Hamburg, Germany. Electronic address: thomas.dobner@leibniz-liv.de., Vitt D; Immunic AG, Gräfelfing, Germany. Electronic address: daniel.vitt@imux.com., Kohlhof H; Immunic AG, Gräfelfing, Germany. Electronic address: hella.kohlhof@imux.com., Hahn F; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: friedrich.hahn@uk-erlangen.de. |
| Source: | Antiviral research [Antiviral Res] 2024 Nov; Vol. 231, pp. 106008. Date of Electronic Publication: 2024 Sep 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
